Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gero Brockhoff

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|July 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor MiceVeruschka Albert, Christina Bruss, Deniz Tümen, et al.
International Journal of Molecular Sciences|December 10, 2021
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell CarcinomaDaniela Schulz, Martin Wetzel, Jonas Eichberger, et al.
Archives of Gynecology and Obstetrics|March 17, 2022
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effectsVeruschka Albert, Gerhard Piendl, Dali Yousseff, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 15, 2015
Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancerTobias Ach, Stephan Schwarz-Furlan, Stephanie Ach, et al.
International Journal of Oncology|September 6, 2007
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomyStefan Denzinger, Robert Stoehr, Stephan Schwarz, et al.
Plastic and Reconstructive Surgery|April 12, 2016
Leukocyte-Reduced Platelet-Rich Plasma Alters Protein Expression of Adipose Tissue-Derived Mesenchymal Stem CellsMarkus Loibl, Siegmund Lang, Alexander Hanke, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 13, 2010
Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitationsArabel Vollmann-Zwerenz, Simone Diermeier-Daucher, Anja Kathrin Wege, et al.
Oncotarget|March 22, 2018
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinomaAlexander Baumann, Anna Maria S Buchberger, Guido Piontek, et al.
Frontiers in Oncology|August 27, 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinomaVerena Schweihofer, Daniela Schulz, Raquel Blazquez, et al.
CNS Oncology|June 20, 2018
Efficacy of D,L-methadone in the treatment of glioblastoma in vitroKonstantin Brawanski, Gero Brockhoff, Peter Hau, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|July 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor MiceVeruschka Albert, Christina Bruss, Deniz Tümen, et al.
International Journal of Molecular Sciences|December 10, 2021
Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell CarcinomaDaniela Schulz, Martin Wetzel, Jonas Eichberger, et al.
Archives of Gynecology and Obstetrics|March 17, 2022
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effectsVeruschka Albert, Gerhard Piendl, Dali Yousseff, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 15, 2015
Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancerTobias Ach, Stephan Schwarz-Furlan, Stephanie Ach, et al.
International Journal of Oncology|September 6, 2007
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomyStefan Denzinger, Robert Stoehr, Stephan Schwarz, et al.
Plastic and Reconstructive Surgery|April 12, 2016
Leukocyte-Reduced Platelet-Rich Plasma Alters Protein Expression of Adipose Tissue-Derived Mesenchymal Stem CellsMarkus Loibl, Siegmund Lang, Alexander Hanke, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 13, 2010
Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitationsArabel Vollmann-Zwerenz, Simone Diermeier-Daucher, Anja Kathrin Wege, et al.
Oncotarget|March 22, 2018
The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinomaAlexander Baumann, Anna Maria S Buchberger, Guido Piontek, et al.
Frontiers in Oncology|August 27, 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinomaVerena Schweihofer, Daniela Schulz, Raquel Blazquez, et al.
CNS Oncology|June 20, 2018
Efficacy of D,L-methadone in the treatment of glioblastoma in vitroKonstantin Brawanski, Gero Brockhoff, Peter Hau, et al.
Pageof 9